News

Ribo Submits Phase 2b Clinical Trial Application for world’s first siRNA FXI inhibitor in atrial fibrillation

Strengthening the link from CMC to clinic

Choosing the Best Oral Dosage Form for Your First-in-Human (FIH) Clinical Trial

Aplagon Doses First Patient in Phase 2a ‘HEALING’ Trial of APAC in PAOD/CLTI

Nordic Regulatory Services – Local Presence and Expertise

Accelerated National Clinical Trial Pathway in Finland

On track to meet the deadline for Vet QRD 9.1 update?

OncoZenge Submits Clinical Trial Application for Pivotal Phase III Trial (BZ003) of BupiZenge™

How LINK Medical, BSI, and Viedoc Enable Smarter Real-World Trials

LINK Medical strengthens its Nordic drug development expertise through the transfer of selected Operations previously part of SDS Life Science AB